Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025. - Zambrano LD; Simeone RM; Newhams MM; Payne AB; Halasa NB; Orzel-Lockwood AO; Calixte JM; Kamidani S; Crandall H; Cameron MA; Schuster JE; Maddux AB; et al. (MMWR. Morbidity and mortality weekly report, 2025)